Report Shows Basic Science Creates Jobs

EQUITY EQUALS SUCCESS: Universities can help start-up ventures by reducing demands for cash, explains licensing officer Mike Martin. A recently issued report has provided new evidence that federal support of basic research in universities earns significant paybacks in the form of jobs created and taxes paid by companies created to exploit research findings. Many institutions have been convinced that they could successfully stimulate start-up companies without losing their academic purity and c

Written byPeter Gwynne
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Mike Martin
EQUITY EQUALS SUCCESS: Universities can help start-up ventures by reducing demands for cash, explains licensing officer Mike Martin.
A recently issued report has provided new evidence that federal support of basic research in universities earns significant paybacks in the form of jobs created and taxes paid by companies created to exploit research findings. Many institutions have been convinced that they could successfully stimulate start-up companies without losing their academic purity and character. Some have put in place administrative systems to facilitate technology transfer by encouraging faculty members and alumni to form companies based on technologies developed in their academic research. Critics of the process, however, wonder whether university authorities have gone too far in their attempt to cash in on their researchers' success.

The report, prepared by the economics department of BankBoston (E. Moscovitch et al., MIT: The Impact of Innovation, Boston, BankBoston, 1997), demonstrates the nationwide job-creation power of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies